According to the report from Yonhap News Agency on August 27th, renowned e-cigarette company Sikary's new brand VFLY has announced a partnership with Somone (VFLY Korea) and will be launching their new product "VFLY C1" for the first time in the Korean market.
VFLY stated that "VFLY C1" represents the pinnacle of e-cigarette technology and has been meticulously designed to enhance user satisfaction and convenience. With the launch of this product, VFLY aims to redefine the standard in the e-cigarette industry and push top-tier e-cigarettes and advanced technology to the forefront.
According to reports, the adjustable three modes are ULTRA, RICH, and TASTY. In TASTY mode, the product can provide up to 25,000 uses. Additionally, the device's screen can display real-time battery usage, remaining e-liquid, and information on different modes.
The "VFLY C1" offers 10 different flavors and has specifically adjusted three localized flavors for the Korean market.
VFLY's leaders in the United States, South Korea, and Japan, Steve Wang, stated that...
The collaboration with Somone played a crucial role in the launch of the 'VFLY C1' product. We are excited to introduce this product to the South Korean market and hope it will become a significant milestone for us. This release marks the beginning of VFLY's commitment to providing innovative and high-quality e-cigarette products to the global market.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
